The goals of the training sessions are to facilitate university students’ ability to recognize and thus helping them fight against fake news focusing on the Russian-Ukrainian war by promoting the understanding of media literacy and media disinformation. This will include six workshops delivered by three internationally acknowledged trainers with expertise in their field. The project focuses on the possible ways of fighting fake news with special focus on the fake media coverage of the Russian-Ukrainian war. This project is a 3-day training session for 15 university students with active students status at BA, MA, ELT, or PhD level.
Project: War or Special Military Operation - Helping Youth Take Up Arms Against Fake News His major goal as an English professor and ESL teacher is to promote the importance of foreign language learning and education. His scope of research is the role of foreign language applied theatre activities in language learning, he also specializes in conducting translation courses and several teacher training courses, bringing to his work a wide range of experience in the field. He delivers courses such as audiovisual translation, electronic media, performing and presentation skills and English for Specific Purposes (ESP). In this role, he coordinates the “English language in the media” specialization for English Studies BA students. He is an assistant professor for the School of English and American Studies at Eötvös Loránd University, Budapest. He holds a PhD in English applied linguistics. Retrieved June 15, 2022.Laszlo Katona is a certified teacher of English language and literature and chemistry.
Press Release: King Pharmaceuticals to Acquire Meridian Medical Technologies ^ National Inventors Hall of Fame Kaplan Sheldon Archived at the Wayback Machine.^ Meridian Medical Technologies 10-K Filing For the fiscal year ended July 31, 1997.^ Bloomberg Meridian profile Page accessed Aug 25, 2016.
Īltaris Capital Partners, LLC entered into an agreement to acquire Meridian Medical Technologies (“Meridian”) from Pfizer on Novemand completed the acquisition on January 4, 2022. Meridian is a member of the Alliance for Biosecurity, which is a group of companies that work towards preventing and treating severe infectious diseases, especially those that present global security challenges. King Pharmaceuticals acquired Meridian in 2003, and the company became part of Pfizer when Pfizer acquired all of King's assets through a process that started in 2010 and was completed in 2011. The EpiPen was marketed and distributed by Dey LP, a subsidiary of Merck KGaA. had been the employer of Sheldon Kaplan, who had invented various kinds of autoinjectors, including the epinephrine autoinjector, EpiPen. It was founded in 1968 as Brunswick Biomedical Corporation and changed its name in November 1996 when it merged with Survival Technology, Inc. Meridian Medical Technologies, LLC is a company which primarily manufactures antidotes for chemical weapons.
0 kommentar(er)
